Position in VCYT
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$18,870,594
+$206,188 QoQ
Shares Held
321,311
-44.5% QoQ
Ownership
0.400%
of shares outstanding
% of Portfolio
0.06%
of 13F equity value
Holder Rank
#49
of 367 holders
Holding Since
Jun 2022
7 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in VCYT Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026FRED ALGER MANAGEMENT, LLC holds $619,082,292 across 13 Diagnostics & Research names. VCYT ranks #3 (3.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | NTRA |
Natera, Inc.
|
1,778,009 | $482,640,542 | |
| 2 | GH |
Guardant Health, Inc.
|
416,566 | $62,497,396 | |
| 3 | VCYT |
Veracyte, Inc.
This page
|
321,311 | $18,870,594 | |
| 4 | BLLN |
BillionToOne, Inc.
|
114,123 | $13,692,477 | |
| 5 | RDNT |
RadNet, Inc.
|
217,394 | $13,406,687 | |
| 6 | IDXX |
Idexx Laboratories Inc /De
|
19,606 | $10,321,382 | |
| 7 | WGS |
GeneDx Holdings Corp.
|
108,527 | $7,450,378 | |
| 8 | CDNA |
CareDx, Inc.
|
170,146 | $4,849,161 |
All Filings in VCYT
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $18,870,594 | 321,311 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $18,664,406 | 579,460 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $26,686,936 | 633,894 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $26,347,552 | 767,479 | Shares | Sole | 2025-11-14 | |
| 2024-12-31 | $1,342,123 | 33,892 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $325,796 | 9,571 | Shares | Sole | 2024-11-14 | |
| 2022-06-30 | $257,565 | 12,943 | Shares | Sole | 2022-08-15 | |
| No filing history on record for this holder in this stock. | ||||||